May 30, 2015
Introduction of a high-sensitivity cardiac troponin T assay into clinical practice resulted in the identification of minor cardiac troponin elevations in a large percentage of patients, many of whom did not have MI, according to new data from the SWEDEHEART Registry.
Researchers analyzed data on 48,594 patients in the large registry who were hospitalized for suspected ACS. All patients were classified based on high-sensitivity cardiac troponin T level: less than 6 ng/L (11.9%); 6 ng/L to 13 ng/L (13.4%); 14 ng/L to 49 ng/L (21.6%); or at least 50 ng/L (53.2%). Researchers used the Elecsys troponin T high-sensitive assay (Roche Diagnostics Corp.).